KBC announced the growth in operating profit; the increase in drug sales was the main factor. KBC announced that the increase of over 30% in operating profit in the 9-month period that ended on September 22, 1405, is mainly due to an increase in operating profit, an improvement in the net profit margin, the implementation of many contracts with the Food and Drug Administration, and the increase in sales.